PTP1B 抑制剂通过 Src 信号传递缓解有害的败血性肺损伤
Chongrong Qiu1,2,3, Zhijian Sun1,3, Fen Liu1,4
1Department of Critical Care Medicine, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No. 17 Yongwaizheng Street, Nanchang, Jiangxi, 330006, China.
Functional & integrative genomics
|October 25, 2024
概括
向蛋白氨酸酸酶1B (PTP1B) 为治疗败血性肺损伤提供了一个新的策略. 抑制PTP1B可以降低炎症并改善败血症模型的结果,解决临床关键需求.
科学领域:
- 肺部医学 肺部医学
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 败血性肺损伤是一个重大的临床挑战,死亡率高,治疗选择有限.
- 无法控制的肺炎是败血症引起的肺损伤的一个关键因素.
- 针对早期的炎症反应可能是一个有效的治疗策略.
研究的目的:
- 调查PTP1B在败血性肺损伤中的作用.
- 探索PTP1B抑制在治疗败血症引起的肺损伤中的治疗潜力.
主要方法:
- 建立了使用结和穿孔的败血性肺损伤模型.
- 使用西式涂抹和免疫光学来评估PTP1B,ER压力和热.
- 使用共免疫沉来分析PTP1B和Src相互作用.
主要成果:
- 在败血性肺损伤模型 (体内和体外) 中,PTP1B的表达被上调.
- PTP1B直接与Src结合,通过ER压力-热的途径加剧炎症.
- 在败血症小鼠中,PTP1B抑制改善了炎症和改善了生存率.
结论:
- PTP1B通过调节ER压力 - 烧伤轴,在败血性肺损伤的发病过程中发挥着关键作用.
- PTP1B 抑制剂在治疗败血性肺损伤方面具有潜在的临床价值.
- 向PTP1B代表了对这种疾病的有前途的新治疗策略.
相关概念视频
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
01:20The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K